Home › Calculator › ARGNF Dividend Calculator 2026
ARGNF Dividend DRIP Calculator 2026
0.20% YieldHealthcareargenx SE · OTC
Price: $1,014.25 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
ARGNF is not a dividend-focused stock
ARGNF pays a very low or no dividend (Yield: 0.20%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ARGNF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ARGNF snowball 📈
$10,000 in ARGNF → $10.26M in 10 years · $1.65/month
About argenx SE (ARGNF) — Dividend Analysis 2026
argenx SE operates as a biotechnology firm, specializing in the advancement of various therapeutic solutions for autoimmune diseases across the United States, the Netherlands, Belgium, Japan, Switzerland, Germany, and France. The company's flagship investigational therapy is efgartigimod, currently undergoing Phase III clinical trials for conditions including myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, and chronic inflammatory demyelinating polyneuropathy. Efgartigimod is also in Phase II/III studies for bullous pemphigoid and idiopathic inflammatory myopathy, with a subcutaneous formulation (ENHANZE SC) in preclinical development. Beyond this primary candidate, argenx SE maintains a pipeline of immunology innovations. These encompass cusatuzumab, aimed at hematological cancer and high-risk myelodysplastic syndromes; ARGX-119, an antibody designed to target muscle-specific tyrosine kinase; ARGX-117 for severe autoimmune indications; ARGX-118, which addresses airway inflammation; and ARGX-120, another treatment for autoimmune disorders. Furthermore, argenx SE is involved in external collaborations for several product candidates. These include ARGX-115 for cancer treatment, ARGX-112 which targets the interleukin-22 receptor, and ARGX-114, an antibody directed against the MET receptor. The company has forged strategic alliances with AbbVie S.À.R.L., Zai Lab Limited, and LEO Pharma A/S. It also maintains an extensive network of collaboration and licensing agreements with partners such as Genor Biopharma Co. Ltd, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., the University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. Established in 2008, argenx SE's headquarters are located in Breda, the Netherlands.
Compare ARGNF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ARGNF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ARGNF position with:
🌍 ARGNF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ARGNF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.20% | -2.60% | $20 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.17% | -2.63% | $17 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.16% | -2.64% | $16 / yr |
| 🇬🇧 UK ISA | 0% | 0.20% | -2.60% | $20 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.18% | -2.62% | $18 / yr |
| 🇨🇦 TFSA | 0% | 0.20% | -2.60% | $20 / yr |
| 🇨🇦 CA Taxable | 25% | 0.15% | -2.65% | $15 / yr |
| 🇦🇺 Super (pension) | 15% | 0.17% | -2.63% | $17 / yr |
| 🇦🇺 AU Taxable | 30% | 0.14% | -2.66% | $14 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.15% | -2.65% | $15 / yr |
| 🇫🇷 FR Taxable | 30% | 0.14% | -2.66% | $14 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ARGNF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ARGNF Dividend Payment Schedule
ARGNF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ARGNF vs Healthcare Benchmarks
How ARGNF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ARGNF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ARGNF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ARGNF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
argenx SE (ARGNF) is currently trading at $1,014.25, trading near its 52-week high. The current dividend yield is 0.20% based on an annual payout of $2.00 per share.
ARGNF (argenx SE) — 0.20% Dividend Yield Analysis
argenx SE (ARGNF) is a healthcare stock currently trading at $1014.25 with a dividend yield of 0.20%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.